Clinical Trials
37 trialsHypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
NRG Oncology
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
National Cancer Institute (NCI)
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NRG Oncology
PSMA PET Response Guided SabR in High Risk Pca
University of Texas Southwestern Medical Center
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
City of Hope Medical Center
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Hackensack Meridian Health
RATIONAL
Ontario Clinical Oncology Group (OCOG)
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Abramson Cancer Center at Penn Medicine
BiolenRT
Alessa Therapeutics Inc.
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Alessa Therapeutics Inc.
BAT-RAD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
University of Washington
Personalized Optimization of Systematic Prostate Biopsy
Fujian Medical University Union Hospital
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
Alpha Tau Medical LTD.
Neoadjuvant Embolization and Cytoreduction in Prostate Cancer
British Columbia Cancer Agency
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
NRG Oncology
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Northwestern University
LDR BURST
Royal Surrey County Hospital NHS Foundation Trust
RAD 2003
University of Alabama at Birmingham
Two-fraction HDR Monotherapy for Localized Prostate Cancer
University of California, San Francisco
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer
Ohio State University Comprehensive Cancer Center
A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
Hoag Memorial Hospital Presbyterian
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes
Emory University
Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer
Peking University First Hospital
SAFO
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Stanford University
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
University of Washington
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Roswell Park Cancer Institute
AtezoVax
University of Utah
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
George Washington University
2STAR
Sunnybrook Health Sciences Centre
AADLPC
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
University of California, San Francisco
Prostate Cancer - Localized Adenocarcinoma Proton Therapy
National Cancer Center, Korea
GEMO
Institut Cancerologie de l'Ouest
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
University of Southern California